Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giuseppe D’Agostino
Observed names:
Giuseppe D'Agostino,
Giuseppe D′Agostino
Institutions:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
Istituti di Ricovero e Cura a Carattere Scientifico,
IRCCS Humanitas Research Hospital
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
Istituti di Ricovero e Cura a Carattere Scientifico,
IRCCS Humanitas Research Hospital
ORCID:
0000-0002-2518-3435
Observed ORCIDs:
0000-0002-2518-3435,
0009-0009-8347-1038
OpenAlex ID:
A5015628985
Correlation between inflammatory biomarkers and disease control in chronic rhinosinusitis with nasal polyps
2024
·
Eugenio De Corso
, Silvia Baroni
, et al.
·
International Forum of Allergy & Rhinology
·
33
PDF
Two‐Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage
2025
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
Allergy
·
29
Comparative real‐world outcomes of dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patients
2024
·
Eugenio De Corso
, Davide Paolo Porru
, et al.
·
Clinical Otolaryngology
·
26
PDF
Blood and local nasal eosinophilia in chronic rhinosinusitis with nasal polyps: prevalence and correlation with severity of disease
2025
·
Eugenio De Corso
, Marco Corbò
, et al.
·
Acta Otorhinolaryngologica Italica
·
21
PDF
Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study
2023
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
European Archives of Oto-Rhino-Laryngology
·
20
Effectiveness of Dupilumab in the Treatment of Adult and Older Adult Patients with Severe, Uncontrolled CRSwNP
2023
·
Giancarlo Ottaviano
, Eugenio De Corso
, et al.
·
Journal of Personalized Medicine
·
17
PDF
Proposal for a Structured Outpatient Clinic for Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps in the First Year of Treatment
2022
·
Sara Torretta
, Eugenio De Corso
, et al.
·
Journal of Personalized Medicine
·
13
PDF
Dupilumab Monthly Dose De‐Escalation Maintains Efficacy in CRSwNP : A Two‐Year Real‐World Study
2025
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
The Laryngoscope
·
10
Adaptive workflow with EQD2 conversion for side effect prediction in prostate re-irradiation
2026
·
Francesco La Fauci
, Giacomo Reggiori
, et al.
·
Physica Medica
Cost Minimization and Cost Comparison of the Use of Conventional Double Lumen Tube versus Single-Use VivaSight-Double Lumen Tube in Thoracic Surgery: The Pascale Institute Experience
2026
·
Maurizio Marchesini
, Michela D'Antò
, et al.
·
ClinicoEconomics and Outcomes Research
PDF
Dupilumab Improves Facial Pain and Reduces Rescue Treatments in Patients with CRSwNP and Recalcitrant Frontal Sinusitis
2024
·
Eugenio De Corso
, Stefano Settimi
, et al.
·
Journal of Personalized Medicine
Show more works
View as search
Works count:
11
Citation count:
169
H-index:
8
I10-index:
8
Year
Topic
Type